COVID-19 may cause long-lasting cognitive and mental issues
A study published in The Lancet Psychiatry reveals that many people who were hospitalized with COVID-19 continue to suffer from cognitive and psychiatric problems...
Common arthritis drug may help treat long COVID
Researchers at the University of Virginia School of Medicine have found a potential treatment for the respiratory symptoms of long COVID by uncovering a...
Mammal-to-mammal spread of bird flu confirmed in new study
A recent study has confirmed that bird flu, specifically the H5N1 strain, has spilled over from birds to dairy cattle in the U.S. and...
Scientists find mild COVID-19 can cause long-term memory and attention issues
Even mild cases of COVID-19 can lead to long-term cognitive problems, including memory loss and attention deficit, according to a study by researchers at...
Long COVID risk has declined over course of pandemic, shows study
The risk of developing long COVID has decreased significantly over the course of the COVID-19 pandemic, according to an analysis of data.
Researchers attributed about...
Vaccination reduces long COVID risk by 70%, new study finds
A new study led by Washington University School of Medicine in St. Louis has found that the risk of developing long COVID has decreased...
Reinfections of COVID-19 likely as severe as initial infection, study finds
A recent study has analyzed health data from nearly 213,000 Americans who experienced reinfections with the virus causing COVID-19.
Researchers found that individuals who had...
COVID-19 reinfections show similar severity to original cases, study finds
A recent study suggests that if you get reinfected with the virus that causes COVID-19, the severity of the second infection will likely be...
Scientists develop “invisible mask” to block 99.8% of airborne viruses
A groundbreaking invention by a University of Michigan startup, Taza Aya, has introduced a new way to protect workers from airborne viruses.
This technology, called...
How dexamethasone saves lives in severe COVID-19
Dexamethasone has become a crucial drug in treating severe COVID-19, but patients' responses to it vary widely.
Researchers at the German Center for Neurodegenerative Diseases...